Triangle Petroleum Corp. (OTCBB: TPLM | Quote | Chart | News | PowerRating) engages in the acquisition, exploration, and development of oil and gas resource properties in the United States and Canada. The company holds interests in the Maritimes Basin of eastern Canada, which contains 361,200 net acres of contiguous oil and gas leaseholds; and Fayetteville Shale of the Arkoma Basin, which comprises 10,437 net acres of oil and gas leaseholds in Arkansas, the U.S. It also has interests in the Rocky Mountains, and the Barnett Shale of Greater Fort Worth Basin, Texas in the United States; and Alberta Deep Basin in western Canada. As of January 31, 2008, Triangle Petroleum Corporation had two producing wells in the Alberta Deep Basin, Canada; and six producing wells in the Barnett Shale of Texas, the United States. The company was incorporated in 2003. It was formerly known as Peloton Resources, Inc. and changed its name to Triangle Petroleum Corporation in 2005. The company is based in Calgary, Canada. With 67.43 million shares outstanding and 59,900 shares declared short as of October 2008, there is a failure to deliver in shares of TPLM. According to quarterly data provided by the SEC, there were still 600,194 shares of TPLM that were failing-to-deliver as of June 27, 2008.
AXM Pharma Inc. (OTC: AXMP | Quote | Chart | News | PowerRating) engages in the manufacture, marketing, and distribution of over-the-counter and prescription pharmaceutical and neutraceutical products primarily in the People's Republic of China. Its products include Asarone, an antiseptic, anti-inflammatory, asthma reducing, and cough prevention tablet; Elegance, a menstrual relief lotion; LiveComf, a compound sulfur cream used to alleviate dermatitis, seborrheica, scabies, acne, and eczema; Bodyward, a tablet to treat allergy caused by penicillin; Reheal, a capsule used to treat reduced memory capacity and impairment of cerebral function caused by acute/chronic cerebrovascular disease, cerebral trauma, and toxic cerebral disease; and LifeGate, an antifatigue capsule used for enhancing energy and vitality. The company also offers a line of vitamin and vitamin supplements. It offers these products through a third party distributor to hospitals and hospital distributors. AXM Pharma also markets its products in Hong Kong, Taiwan, Korea, the Philippines, Indonesia, Malaysia, Singapore, and Thailand. As of December 31, 2005, it held 42 licenses to produce over-the-counter and prescription pharmaceutical products in China. The company was founded in 1999. It was formerly known as Wholesale on the Net, Inc. and changed its name to Wickliffe International Corporation in 2001. Further, the company changed its name to AXM Pharma, Inc. in 2003. AXM Pharma is headquartered in Las Vegas, Nevada. With 22.41 million shares outstanding and 141,300 shares declared short as of October 2008, there is a failure to deliver in shares of AXMP. According to quarterly data provided by the SEC, there were still 426,137 shares of AXMP that were failing-to-deliver as of June 21, 2007.
Bombardier Inc. (OTC: BDRBF | Quote | Chart | News | PowerRating) operates as a global transportation company worldwide. It operates in two businesses, Aerospace and Transportation. The Aerospace business designs and manufactures aviation products and provides services for the commercial, business, and amphibious aircraft markets. It also offers Bombardier Flexjet fractional ownership, aircraft charter and management, technical services, and aircraft maintenance and pilot training for business, commercial airline, and military customers. The Transportation business involves in the rail equipment manufacturing and servicing, which comprises passenger rail vehicles and total transit systems, locomotives, bogies, and propulsion and controls, as well as provides rail control solutions. The company was founded in 1902 and is based in Montreal, Canada. With 1.44 billion shares outstanding and 5.72 million shares declared short as of October 2008, there is a failure to deliver in shares of BDRBF. According to quarterly data provided by the SEC, there were still 2,483,590 shares of BDRBF that were failing-to-deliver as of February 25, 2005.
Galleon Energy Inc (OTC: GLNYF | Quote | Chart | News | PowerRating) engages in the exploration for and acquisition and development of petroleum and natural gas properties in western Canada. It owns oil and gas property interests in the Eaglesham/Kakut and Shadow areas of Alberta. The company is based in Calgary, Canada. With 67.6 million shares outstanding and 177,600 shares declared short as of October 2008, there is a failure to deliver in shares of GLNYF. According to quarterly data provided by the SEC, there were still 25,997 shares of GLNYF that were failing-to-deliver as of April 21, 2008.
Peyto Energy Trust Unit (OTC: PEYUF | Quote | Chart | News | PowerRating) operates as an open-ended limited purpose trust in Canada. The company, through its subsidiaries, engages in the acquisition, exploration, development, and production of oil and natural gas in Alberta's deep basin. As of December 31, 2007, it had total proved plus probable reserves of approximately 164.8 million barrels of oil equivalent. Peyto Energy Trust was founded in 1997 and is based in Calgary, Canada. With 105.7 million shares outstanding and 591,000 shares declared short as of October 2008, there is a failure to deliver in shares of PEYUF. According to quarterly data provided by the SEC, there were still 426,559 shares of PEYUF that were failing-to-deliver as of June 20, 2005.
Publicis Groupe S.A. (OTC: PUBGY | Quote | Chart | News | PowerRating) provides traditional advertising, specialized agencies and marketing services, and media services for customers in Europe, North America, and internationally. The company's traditional advertising services include the creation of advertising for products, services, and brands; and market research, consumer behavior studies, and sociological and psychological studies. It also offers specialized communication services, such as direct marketing and customer relationship management, sales promotion and point-of-sale marketing, healthcare communications, multicultural and ethnic communications, corporate and financial communications, human resources communications, public relations, design services, interactive communications, events marketing, and production and pre-press technologies. In addition, the company provides media operations services, including media planning, media buying, and media sales. Further, the company, through its subsidiary, offers digital communication and direct marketing services, as well as marketing services in the health sector. Publicis has strategic alliance with Dentsu, Inc. The company was founded in 1926 and is based in Paris, France. With 194.44 million shares outstanding and 160,600 shares declared short as of October 2008, there is a failure to deliver in shares of PUBGY. According to quarterly data provided by the SEC, there were still 269,302 shares of PUBGY that were failing-to-deliver as of September 12, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,300,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index